The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue
| Autor: | Beechinor, Ryan J., Mohyuddin, Ghulam Rehman, Mitchell, David E., Aaron, Daniel, Mahmoudjafari, Zahra |
|---|---|
| Zdroj: | In Journal of Cancer Policy December 2023 38 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect